Developer docs
API playgroundTry for free, no card

Search company profiles

Genoscreen

Full company profile

uuid000a7tz

Namestring
Genoscreen
Legal namestring
GenoScreen
Websiteurl
genoscreen.fr
Company typeenum
Private
Founded yearint
2001
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLille, France
HQ citystring
Lille
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomic sequencing services, bioinformatics analysis, molecular diagnostics, microbiome analysis, regulatory compliance services
Industry3 codes
PRIMARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Genomic & Bioinformatics Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Genomic services
TypeProfessional Services
Description

Sequencing, genotyping, and bioinformatics analysis services provided to clients including biotechs, pharmaceutical companies, research institutions, and agricultural companies

genoscreen.fr
2Specialized diagnostic products
TypeOne Time License
Description

Deeplex product line (Deeplex Myc-TB, Deeplex Myc-Lep, Deeplex HelP) for molecular diagnostics of pathogens with integrated interpretation algorithms

genoscreen.fr
3Training courses
TypeProfessional Services
Description

Genomics technology training courses for researchers, biologists and doctors covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variants search

genoscreen.fr
4Custom genomic services
TypeProfessional Services
Description

Custom analytical protocols tailored to specific research objectives including oligonucleotide design, DNA/RNA extraction, PCR optimization, library preparation, and genomic analysis

genoscreen.fr
5Regulatory compliance services
TypeProfessional Services
Description

EFSA-compliant testing and dossier preparation for Novel Food, food enzymes, feed additives, and biofertilizers/biocontrol products

genoscreen.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

GenoScreen is a B2B genomic and metagenomic services company that sells sequencing (NGS whole-genome, long-read, targeted, metagenomics, transcriptomics, and Sanger), genotyping (MIRU-VNTR, MLVA, SNP, microsatellite), and bioinformatics analysis to biotech, pharma, agro-industry/biosolutions, cosmetics, animal nutrition, academic, and clinical customers. It also markets the Deeplex line of targeted amplicon-based molecular diagnostic kits (Myc-TB, Myc-Lep, HelP) with integrated interpretation algorithms, and provides EFSA/FDA regulatory-dossier services (Novel Food, food/feed enzymes and additives, biofertilizers, biocontrol) backed by over 20 years of microorganism-study experience.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Predicts tuberculosis antibiotic resistance in 48 hours for 15 principal antibiotics
+1 more record
Product overview1 text field

GenoScreen is a genomic and metagenomic solutions company offering sequencing, genotyping, and bioinformatics services with specialized expertise in microbiology. The company provides a comprehensive portfolio including molecular diagnostic tests (Deeplex product line for mycobacteria and Helicobacter pylori identification and resistance prediction), next-generation sequencing services (whole genome sequencing, transcriptomics, metagenomics, targeted sequencing), genotyping services (MIRU-VNTR, SNP, microsatellite, microbial typing), microbiome analysis solutions (GenoBiome, skin microbiome, shotgun metagenomics, metatranscriptomics), and bioinformatics services (de novo assembly, genome annotation, variant detection, differential expression analysis). The company also offers regulatory compliance services for EFSA Novel Food, Feed Additives, Food Enzymes, and Biofertiliser/Biocontrol products, combining genomic analysis with dossier preparation for European market authorization. A strategic partnership with Staphyt extends capabilities into regulatory studies and field trials for agricultural biosolutions.

Product and service22 records
1Deeplex Myc-TB
CategoryMolecular Diagnostic Test
Description

A molecular diagnostic test for rapid identification of mycobacteria and prediction of resistance to 15 principal anti-tuberculosis antibiotics in 48 hours, based on deep amplicon sequencing technology; targeted at tuberculosis reference laboratories and clinical diagnostics programs.

2Deeplex Myc-Lep
CategoryMolecular Diagnostic Test
Description

Deeplex Myc-Lep enables high-resolution genotyping and multidrug resistance prediction for Mycobacterium leprae directly from patient biopsies; targeted at clinical and reference laboratories working on leprosy diagnostics.

3Deeplex HelP
CategoryMolecular Diagnostic Test
Description

A targeted deep amplicon sequencing test for Helicobacter pylori identification and resistance prediction; targeted at clinical microbiology laboratories and infectious disease reference centers.

4MIRU-VNTR (Mycobacterium tuberculosis genotyping)
CategoryGenotyping Method
Description

Mycobacterial Interspersed Repetitive Unit-Variable Number of Tandem Repeat (MIRU-VNTR) analysis for Mycobacterium tuberculosis genotyping and epidemiological tracking; targeted at public-health and tuberculosis reference laboratories.

5Brucella MLVA-16
CategoryMolecular Typing Product
Description

Multiple Locus VNTR Analysis (MLVA-16) for Brucella species typing and surveillance; targeted at veterinary, food-safety, and reference laboratories.

6Whole Genome Sequencing (WGS)
CategoryNGS Service
Description

Complete genome sequencing using a hybrid long-read and short-read approach for high-quality genome assembly, including EFSA-compliant WGS for regulatory dossiers; targeted at biotech, agro-biosolutions, and academic customers needing high-quality microbial genomes.

7Transcriptomics (RNA sequencing)
CategoryNGS Service
Description

RNA sequencing service for whole-transcriptome analysis and differential gene expression studies; targeted at academic and industrial microbiology researchers.

8Metagenomics (NGS)
CategoryNGS Service
Description

Metagenomic sequencing for analysis of complex microbial communities from environmental and clinical samples; targeted at academic and industrial microbiome research programs.

9Targeted Sequencing
CategoryNGS Service
Description

Amplicon-based targeted sequencing for specific genomic regions of interest; targeted at customers studying defined microbial targets such as resistance genes.

10Sanger Sequencing
CategorySequencing Service
Description

Traditional Sanger sequencing service including molecular barcoding for sample identification; targeted at academic and industrial customers needing confirmation sequencing.

11Long Read Sequencing
CategoryNGS Service
Description

Long-read sequencing service for improved genome assembly and structural variant detection; targeted at biotech and academic customers needing high-contiguity assemblies.

12SSR Microsatellite Genotyping
CategoryGenotyping Service
Description

Microsatellite marker analysis for genetic characterization and strain typing; targeted at academic, agricultural, and food-safety customers.

13SNP Genotyping
CategoryGenotyping Service
Description

Single nucleotide polymorphism detection for genetic variation analysis; targeted at researchers and industrial customers analyzing genetic variation.

14Microbial Typing and Tracking
CategoryGenotyping Service
Description

Molecular typing services for microbial strain identification and epidemiological tracking; targeted at reference laboratories and public-health surveillance programs.

15Bioinformatics Analysis Services
CategoryBioinformatics Service
Description

Comprehensive bioinformatics services covering de novo assembly, genome annotation, genome comparisons, mutation detection, differential gene expression analysis, and interactive bioinformatic reporting using proprietary interpretation algorithms; targeted at biotech, academic, and industrial customers outsourcing bioinformatics interpretation.

16GenoBiome (Microbiome Analysis)
CategoryMicrobiome Analysis Product
Description

Proprietary microbiome analysis solution for characterization of microbial communities (bacteria, yeasts, fungi, algae) from various sample types, using culture-free molecular analysis; targeted at health, cosmetics, animal nutrition, and environmental customers.

17Skin Microbiome Analysis
CategoryMicrobiome Analysis Service
Description

Specialized analysis of skin microbiota for cosmetic and dermatological research applications; targeted at cosmetic and dermatological research customers.

18Training Courses in Genomics
CategoryTraining Service
Description

Expert-led training courses covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variant searching; targeted at researchers, biologists, and doctors seeking hands-on genomics upskilling.

19EFSA Novel Food Dossier Services
CategoryRegulatory Service
Description

Comprehensive genomic characterization for EFSA Novel Food regulatory submissions, including Whole Genome Sequencing, antimicrobial resistance gene analysis, virulence factor screening, and dossier preparation; targeted at food and probiotic companies seeking Novel Food approval in Europe.

20Feed Additives & Enzymes Regulatory Services
CategoryRegulatory Service
Description

Regulatory support for feed additives and enzymes involving microorganisms, including genomic characterization for safety assessments; targeted at animal nutrition and feed-industry customers.

21Food Enzymes & Additives Regulatory Services
CategoryRegulatory Service
Description

Genomic analysis and dossier preparation for food enzyme and food additive regulatory approvals; targeted at food-industry customers needing EFSA compliance.

22Biofertiliser & Biocontrol Regulatory Services
CategoryRegulatory Service
Description

Regulatory compliance services for biofertilizers and biocontrol products, including genomic characterization for European market authorization; targeted at agro-industry and biosolutions customers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Strategic collaboration agreement combining GenoScreen's genomic technologies with Staphyt's regulatory studies and field trial capabilities. Partnership provides integrated services for agricultural product development, supporting the full product lifecycle from scientific validation to regulatory approval. Primarily targets agro-industry and biosolutions companies developing microbial products including biostimulants and biocontrol solutions subject to European standards.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Strategic collaboration to address growing regulatory and scientific complexity in the biosolutions sector. Integration of genomic data analysis with regulatory studies and field trials for microbial product development and regulation compliance in Europe.

3Institut Polytechnique UniLaSalle
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in ADAGIO project (2019-2022) - a collaborative research initiative proposing innovative nutritional solutions (calcium butyrate + ellagitannins + fiber) to improve digestive health and comfort in monogastric farm animals.

genoscreen.fr
4Sanluc International
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in ADAGIO project for innovative nutritional solutions for monogastric farm animals

genoscreen.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in ADAGIO project for innovative nutritional solutions for monogastric farm animals

6Université de Gand
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in ADAGIO project for innovative nutritional solutions for monogastric farm animals

genoscreen.fr
7ADEME
Strategic tierMinorTypeOthers
Description

Funding partner for BIMM-SOL project (2016-2018) - industrialization of procedures for analysis of molecular microbial bioindicators for qualitative biological diagnosis of soils. Also funded BioDISSPOL project for microbial biomarkers in chlorinated solvent-polluted site diagnosis.

genoscreen.fr
8European Interreg France-Wallonie-Vlaanderen
Strategic tierMinorTypeOthers
Description

European funding program for ADAGIO project (2019-2022) on innovative nutritional solutions for monogastric farm animals

genoscreen.fr
9National Tuberculosis Reference Centers (Africa/Europe)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partners in DIAMA project (2016-2021) - evaluating and validating Deeplex Myc-TB test in Africa and Europe for rapid molecular diagnosis of tuberculosis and drug resistance prediction. Partners include centers from Belgium, Mali, UK, Guinea, Ethiopia, Congo, Rwanda, Senegal, Cameroon, and WHO.

genoscreen.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in FLU-MICROBIOT project (2015-2018) studying the role of microbiotas and the gastrointestinal/pulmonary axis in respiratory diseases caused by influenza

11CNRS
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in FLU-MICROBIOT project on gut-lung axis in influenza

genoscreen.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in FLU-MICROBIOT project on gut-lung axis in influenza

13Université Fédérale du Minas Gerais
Strategic tierMinorTypeStrategic or Co-development Partner
Description

International partner in FLU-MICROBIOT project on gut-lung axis in influenza

genoscreen.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in BioDISSPOL project (2015-2018) for development of microbial biomarkers for diagnosis and monitoring of chlorinated solvent-polluted sites

15Université de Strasbourg
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in BioDISSPOL project for microbial biomarkers in polluted site diagnosis

genoscreen.fr
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner in MICROTYPE project (2014-2018) for global surveillance of infectious agents like Brucella through development of typing kits and databases

Strategic tierMinorTypeOthers
Description

Funding partner for FLU-MICROBIOT project (2015-2018) studying gut-lung axis in influenza

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Danish microbial genomics service provider focused on microbiome analysis, metagenomics, and microbial characterization for industrial and academic customers. Closely comparable niche positioning to GenoScreen's GenoBiome and microbial services.

TypeBroad incumbent
Description

UK-based life sciences group offering genomic services, reference materials, and molecular biology reagents. Broad incumbent overlapping with GenoScreen in genomic services and genotyping for academic and industrial customers.

TypeDirect peer
Description

Global genomics services company providing NGS, Sanger, and bioinformatics with a strong microbial and clinical research focus. Direct peer in sequencing service menu and target customers, with significantly larger global scale.

TypeBroad incumbent
Description

European leader in genomic services including sequencing, genotyping, and bioinformatics for pharma, food, and academic clients. Operates at much larger scale than GenoScreen with broader portfolio and global footprint, making it the dominant broad incumbent in the same space.

TypeDirect peer
Description

Swiss DNA sequencing and bioinformatics services provider serving pharma, academic, and industrial customers across Europe. Closely comparable in service model, sequencing menu (NGS, Sanger, long-read), and European SME customer profile.

TypeBroad incumbent
Description

French in vitro diagnostics leader with a strong microbiology portfolio including TB diagnostics and antimicrobial resistance testing. Comparable French domicile and infectious disease diagnostics overlap with GenoScreen's Deeplex products, though bioMérieux operates at vastly larger scale.

TypeDirect peer
Description

Global NGS services provider with deep sequencing capacity, bioinformatics, and microbial/clinical applications. Direct competitor in genomic services for academic and industrial customers, with much larger scale.

TypeDirect peer
Description

Dutch microbial genomics specialist offering sequencing, metagenomics, and bioinformatics with a strong microbial focus similar to GenoScreen. Directly comparable in microbiome/microbial services positioning and European academic-industrial customer base.

TypeDirect peer
Description

Swiss genomics services company offering NGS, Sanger, and bioinformatics with a long-standing focus on European academic and biotech clients. Comparable service menu and similar scale to GenoScreen.

TypeBroad incumbent
Description

French clinical diagnostics laboratory network offering specialty testing including infectious disease and molecular diagnostics. Comparable French base and clinical diagnostics adjacency, though focused on routine clinical testing rather than microbial genomics services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genoscreen

Genomic & Bioinformatics Servicesgenoscreen.fr

Genoscreen firmographics

Firmographics
Name
Genoscreen
Legal name
GenoScreen
Website
https://genoscreen.fr
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Genoscreen industry classification

Industry
Product category
Genomic & Bioinformatics Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms

Keywords

  • Genomic sequencing services
  • Bioinformatics analysis
  • Molecular diagnostics
  • Microbiome analysis
  • Regulatory compliance services

Where Genoscreen is headquartered

Location

Headquarters

HQ city
Lille
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Genoscreen business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Genomic services: Sequencing, genotyping, and bioinformatics analysis services provided to clients including biotechs, pharmaceutical companies, research institutions, and agricultural companies
  2. Specialized diagnostic products: Deeplex product line (Deeplex Myc-TB, Deeplex Myc-Lep, Deeplex HelP) for molecular diagnostics of pathogens with integrated interpretation algorithms
  3. Training courses: Genomics technology training courses for researchers, biologists and doctors covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variants search
  4. Custom genomic services: Custom analytical protocols tailored to specific research objectives including oligonucleotide design, DNA/RNA extraction, PCR optimization, library preparation, and genomic analysis
  5. Regulatory compliance services: EFSA-compliant testing and dossier preparation for Novel Food, food enzymes, feed additives, and biofertilizers/biocontrol products

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Genoscreen product offering

Product offering

Core offering

GenoScreen is a B2B genomic and metagenomic services company that sells sequencing (NGS whole-genome, long-read, targeted, metagenomics, transcriptomics, and Sanger), genotyping (MIRU-VNTR, MLVA, SNP, microsatellite), and bioinformatics analysis to biotech, pharma, agro-industry/biosolutions, cosmetics, animal nutrition, academic, and clinical customers. It also markets the Deeplex line of targeted amplicon-based molecular diagnostic kits (Myc-TB, Myc-Lep, HelP) with integrated interpretation algorithms, and provides EFSA/FDA regulatory-dossier services (Novel Food, food/feed enzymes and additives, biofertilizers, biocontrol) backed by over 20 years of microorganism-study experience.

Product overview

GenoScreen is a genomic and metagenomic solutions company offering sequencing, genotyping, and bioinformatics services with specialized expertise in microbiology. The company provides a comprehensive portfolio including molecular diagnostic tests (Deeplex product line for mycobacteria and Helicobacter pylori identification and resistance prediction), next-generation sequencing services (whole genome sequencing, transcriptomics, metagenomics, targeted sequencing), genotyping services (MIRU-VNTR, SNP, microsatellite, microbial typing), microbiome analysis solutions (GenoBiome, skin microbiome, shotgun metagenomics, metatranscriptomics), and bioinformatics services (de novo assembly, genome annotation, variant detection, differential expression analysis). The company also offers regulatory compliance services for EFSA Novel Food, Feed Additives, Food Enzymes, and Biofertiliser/Biocontrol products, combining genomic analysis with dossier preparation for European market authorization. A strategic partnership with Staphyt extends capabilities into regulatory studies and field trials for agricultural biosolutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Deeplex Myc-TB A molecular diagnostic test for rapid identification of mycobacteria and prediction of resistance to 15 principal anti-tuberculosis antibiotics in 48 hours, based on deep amplicon sequencing technology; targeted at tuberculosis reference laboratories and clinical diagnostics programs.
  • Deeplex Myc-Lep Deeplex Myc-Lep enables high-resolution genotyping and multidrug resistance prediction for Mycobacterium leprae directly from patient biopsies; targeted at clinical and reference laboratories working on leprosy diagnostics.
  • Deeplex HelP A targeted deep amplicon sequencing test for Helicobacter pylori identification and resistance prediction; targeted at clinical microbiology laboratories and infectious disease reference centers.
  • MIRU-VNTR (Mycobacterium tuberculosis genotyping) Mycobacterial Interspersed Repetitive Unit-Variable Number of Tandem Repeat (MIRU-VNTR) analysis for Mycobacterium tuberculosis genotyping and epidemiological tracking; targeted at public-health and tuberculosis reference laboratories.
  • Brucella MLVA-16 Multiple Locus VNTR Analysis (MLVA-16) for Brucella species typing and surveillance; targeted at veterinary, food-safety, and reference laboratories.
  • Whole Genome Sequencing (WGS) Complete genome sequencing using a hybrid long-read and short-read approach for high-quality genome assembly, including EFSA-compliant WGS for regulatory dossiers; targeted at biotech, agro-biosolutions, and academic customers needing high-quality microbial genomes.
  • Transcriptomics (RNA sequencing) RNA sequencing service for whole-transcriptome analysis and differential gene expression studies; targeted at academic and industrial microbiology researchers.
  • Metagenomics (NGS) Metagenomic sequencing for analysis of complex microbial communities from environmental and clinical samples; targeted at academic and industrial microbiome research programs.
  • Targeted Sequencing Amplicon-based targeted sequencing for specific genomic regions of interest; targeted at customers studying defined microbial targets such as resistance genes.
  • Sanger Sequencing Traditional Sanger sequencing service including molecular barcoding for sample identification; targeted at academic and industrial customers needing confirmation sequencing.
  • Long Read Sequencing Long-read sequencing service for improved genome assembly and structural variant detection; targeted at biotech and academic customers needing high-contiguity assemblies.
  • SSR Microsatellite Genotyping Microsatellite marker analysis for genetic characterization and strain typing; targeted at academic, agricultural, and food-safety customers.
  • SNP Genotyping Single nucleotide polymorphism detection for genetic variation analysis; targeted at researchers and industrial customers analyzing genetic variation.
  • Microbial Typing and Tracking Molecular typing services for microbial strain identification and epidemiological tracking; targeted at reference laboratories and public-health surveillance programs.
  • Bioinformatics Analysis Services Comprehensive bioinformatics services covering de novo assembly, genome annotation, genome comparisons, mutation detection, differential gene expression analysis, and interactive bioinformatic reporting using proprietary interpretation algorithms; targeted at biotech, academic, and industrial customers outsourcing bioinformatics interpretation.
  • GenoBiome (Microbiome Analysis) Proprietary microbiome analysis solution for characterization of microbial communities (bacteria, yeasts, fungi, algae) from various sample types, using culture-free molecular analysis; targeted at health, cosmetics, animal nutrition, and environmental customers.
  • Skin Microbiome Analysis Specialized analysis of skin microbiota for cosmetic and dermatological research applications; targeted at cosmetic and dermatological research customers.
  • Training Courses in Genomics Expert-led training courses covering NGS data quality control, de novo assembly, BLAST mastery, and genetic variant searching; targeted at researchers, biologists, and doctors seeking hands-on genomics upskilling.
  • EFSA Novel Food Dossier Services Comprehensive genomic characterization for EFSA Novel Food regulatory submissions, including Whole Genome Sequencing, antimicrobial resistance gene analysis, virulence factor screening, and dossier preparation; targeted at food and probiotic companies seeking Novel Food approval in Europe.
  • Feed Additives & Enzymes Regulatory Services Regulatory support for feed additives and enzymes involving microorganisms, including genomic characterization for safety assessments; targeted at animal nutrition and feed-industry customers.
  • Food Enzymes & Additives Regulatory Services Genomic analysis and dossier preparation for food enzyme and food additive regulatory approvals; targeted at food-industry customers needing EFSA compliance.
  • Biofertiliser & Biocontrol Regulatory Services Regulatory compliance services for biofertilizers and biocontrol products, including genomic characterization for European market authorization; targeted at agro-industry and biosolutions customers.

Quantifiable outcome

  • Predicts tuberculosis antibiotic resistance in 48 hours for 15 principal antibiotics
  • +1 more outcomes

Companies that use Genoscreen

Customer profile

Segments9 records

Ideal customer profiles2 records

Genoscreen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Genoscreen partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and minor.

  • StaphytcoreStrategic or Co-development Partner · 21 January 2026Strategic collaboration agreement combining GenoScreen's genomic technologies with Staphyt's regulatory studies and field trial capabilities. Partnership provides integrated services for agricultural product development, supporting the full product lifecycle from scientific validation to regulatory approval. Primarily targets agro-industry and biosolutions companies developing microbial products including biostimulants and biocontrol solutions subject to European standards.
  • StaphytcoreStrategic or Co-development Partner · 21 January 2026Strategic collaboration to address growing regulatory and scientific complexity in the biosolutions sector. Integration of genomic data analysis with regulatory studies and field trials for microbial product development and regulation compliance in Europe.
  • Institut Polytechnique UniLaSalleminorStrategic or Co-development PartnerPartner in ADAGIO project (2019-2022) - a collaborative research initiative proposing innovative nutritional solutions (calcium butyrate + ellagitannins + fiber) to improve digestive health and comfort in monogastric farm animals.
  • Sanluc InternationalminorStrategic or Co-development PartnerPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
  • ALGOFIT SolutionsminorStrategic or Co-development PartnerPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
  • Université de GandminorStrategic or Co-development PartnerPartner in ADAGIO project for innovative nutritional solutions for monogastric farm animals
  • ADEMEminorOthersFunding partner for BIMM-SOL project (2016-2018) - industrialization of procedures for analysis of molecular microbial bioindicators for qualitative biological diagnosis of soils. Also funded BioDISSPOL project for microbial biomarkers in chlorinated solvent-polluted site diagnosis.
  • European Interreg France-Wallonie-VlaanderenminorOthersEuropean funding program for ADAGIO project (2019-2022) on innovative nutritional solutions for monogastric farm animals
  • National Tuberculosis Reference Centers (Africa/Europe)coreStrategic or Co-development PartnerPartners in DIAMA project (2016-2021) - evaluating and validating Deeplex Myc-TB test in Africa and Europe for rapid molecular diagnosis of tuberculosis and drug resistance prediction. Partners include centers from Belgium, Mali, UK, Guinea, Ethiopia, Congo, Rwanda, Senegal, Cameroon, and WHO.
  • INSERMminorStrategic or Co-development PartnerPartner in FLU-MICROBIOT project (2015-2018) studying the role of microbiotas and the gastrointestinal/pulmonary axis in respiratory diseases caused by influenza
  • CNRSminorStrategic or Co-development PartnerPartner in FLU-MICROBIOT project on gut-lung axis in influenza
  • Institut Pasteur de LilleminorStrategic or Co-development PartnerPartner in FLU-MICROBIOT project on gut-lung axis in influenza
  • Université Fédérale du Minas GeraisminorStrategic or Co-development PartnerInternational partner in FLU-MICROBIOT project on gut-lung axis in influenza
  • BRGMminorStrategic or Co-development PartnerPartner in BioDISSPOL project (2015-2018) for development of microbial biomarkers for diagnosis and monitoring of chlorinated solvent-polluted sites
  • Université de StrasbourgminorStrategic or Co-development PartnerPartner in BioDISSPOL project for microbial biomarkers in polluted site diagnosis
  • INRAEminorStrategic or Co-development PartnerPartner in MICROTYPE project (2014-2018) for global surveillance of infectious agents like Brucella through development of typing kits and databases
  • BpiFranceminorOthersFunding partner for FLU-MICROBIOT project (2015-2018) studying gut-lung axis in influenza

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Genoscreen competitors and assessment

Company assessment

Emerging players

  • DNASense: Danish microbial genomics service provider focused on microbiome analysis, metagenomics, and microbial characterization for industrial and academic customers. Closely comparable niche positioning to GenoScreen's GenoBiome and microbial services.

Broad incumbents

  • LGC Group (Biosearch Technologies): UK-based life sciences group offering genomic services, reference materials, and molecular biology reagents. Broad incumbent overlapping with GenoScreen in genomic services and genotyping for academic and industrial customers.
  • Eurofins Genomics: European leader in genomic services including sequencing, genotyping, and bioinformatics for pharma, food, and academic clients. Operates at much larger scale than GenoScreen with broader portfolio and global footprint, making it the dominant broad incumbent in the same space.
  • bioMérieux: French in vitro diagnostics leader with a strong microbiology portfolio including TB diagnostics and antimicrobial resistance testing. Comparable French domicile and infectious disease diagnostics overlap with GenoScreen's Deeplex products, though bioMérieux operates at vastly larger scale.
  • Cerba Healthcare: French clinical diagnostics laboratory network offering specialty testing including infectious disease and molecular diagnostics. Comparable French base and clinical diagnostics adjacency, though focused on routine clinical testing rather than microbial genomics services.

Direct peers

  • Macrogen: Global genomics services company providing NGS, Sanger, and bioinformatics with a strong microbial and clinical research focus. Direct peer in sequencing service menu and target customers, with significantly larger global scale.
  • Microsynth: Swiss DNA sequencing and bioinformatics services provider serving pharma, academic, and industrial customers across Europe. Closely comparable in service model, sequencing menu (NGS, Sanger, long-read), and European SME customer profile.
  • Novogene: Global NGS services provider with deep sequencing capacity, bioinformatics, and microbial/clinical applications. Direct competitor in genomic services for academic and industrial customers, with much larger scale.
  • BaseClear: Dutch microbial genomics specialist offering sequencing, metagenomics, and bioinformatics with a strong microbial focus similar to GenoScreen. Directly comparable in microbiome/microbial services positioning and European academic-industrial customer base.
  • Fasteris: Swiss genomics services company offering NGS, Sanger, and bioinformatics with a long-standing focus on European academic and biotech clients. Comparable service menu and similar scale to GenoScreen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Genoscreen social profiles

Digital presence

Genoscreen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genoscreen leadership team

Management profile

Number of profiles

Profiles3 records

Genoscreen funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genoscreen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genoscreen

What does Genoscreen do?

GenoScreen is a B2B genomic and metagenomic services company that sells sequencing (NGS whole-genome, long-read, targeted, metagenomics, transcriptomics, and Sanger), genotyping (MIRU-VNTR, MLVA, SNP, microsatellite), and bioinformatics analysis to biotech, pharma, agro-industry/biosolutions, cosmetics, animal nutrition, academic, and clinical customers. It also markets the Deeplex line of targeted amplicon-based molecular diagnostic kits (Myc-TB, Myc-Lep, HelP) with integrated interpretation algorithms, and provides EFSA/FDA regulatory-dossier services (Novel Food, food/feed enzymes and additives, biofertilizers, biocontrol) backed by over 20 years of microorganism-study experience.

Is Genoscreen a public or private company?

Genoscreen is a private company. It is classified as unknown and is currently operating.

When was Genoscreen founded?

Genoscreen was founded in 2001. It employs 11 to 50 people.

Where is Genoscreen based?

Genoscreen is headquartered in Lille, France, in the Europe region.

How does Genoscreen make money?

Five revenue lines are on record. Genomic services are the primary driver. The others are specialized diagnostic products, training courses, custom genomic services and regulatory compliance services.

Who are Genoscreen's main competitors?

DNASense is listed as an emerging player. Broad incumbents are LGC Group (Biosearch Technologies), Eurofins Genomics, bioMérieux and Cerba Healthcare. Direct peers are Macrogen, Microsynth, Novogene, BaseClear and Fasteris.

Does Genoscreen have an API?

No public API is recorded for Genoscreen.

What industry is Genoscreen in?

Genoscreen's product category is Genomic & Bioinformatics Services. Its primary akta.pro industry code is HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support), with a secondary code of HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seed WorldCollaboration Links Genomic Analysis with Regulatory Studies and Field TrialsStaphyt and GenoScreen have signed a collaboration agreement to combine their expertise in genomics and regulatory studies to support the development and regulation of microbial products. The partnership aims to provide integrated services from field trials to genomic data for regulatory compliance, primarily in Europe.iGrow NewsStaphyt and GenoScreen Form Strategic Partnership to Support Agricultural Product DevelopmentStaphyt and GenoScreen have announced a strategic collaboration agreement to provide integrated services for agricultural product development, combining GenoScreen's genomic technologies with Staphyt's regulatory studies and field trial capabilities. The partnership targets agro-industry and biosolutions companies developing microbial products, supporting the full product lifecycle from scientific validation to regulatory approval. Both organizations aim to address growing regulatory and scientific complexity in the biosolutions sector, particularly for products like biostimulants and biocontrol solutions subject to European standards.PR NewswireWorld TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in AfricaIllumina Inc. and GenoScreen launched a combined Next Generation Sequencing package on World TB Day 2023 to expand access to genomic testing for tuberculosis drug resistance detection in Africa. The Deeplex Myc-TB assay can identify resistance to 15 antibiotics within 24-48 hours from primary respiratory samples, addressing a critical gap where only 30% of multidrug-resistant TB cases are currently detected. The partnership aims to advance the WHO's goal of ending the global TB epidemic by 2035, with Africa bearing 36% of all TB deaths worldwide.PR NewswireIllumina et GenoScreen font cause commune pour élargir l'accès au dépistage génomique de la tuberculose multirésistanteIllumina and GenoScreen announced a partnership to expand global access to genomic testing for multidrug-resistant tuberculosis (MDR-TB) by combining Illumina's sequencing platforms with GenoScreen's Deeplex® Myc-TB test, enabling resistance detection across 15 antibiotics in 24–48 hours directly from patient samples. The collaboration targets the countries most affected by TB and supports the WHO's goal of ending the global TB epidemic by 2035, addressing a critical gap where only 40% of an estimated 465,000 MDR-TB cases were detected and enrolled in treatment in 2019. TB deaths rose in 2020 for the first time in a decade due to COVID-19 disruptions, underscoring the urgency of faster, more comprehensive diagnostic tools.PR NewswireIllumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant TuberculosisIllumina and GenoScreen announced a partnership to expand access to genomic testing for multidrug-resistant tuberculosis (MDR-TB) in countries most impacted by the disease. The combined solution pairs Illumina's sequencing platforms with GenoScreen's Deeplex Myc-TB assay, enabling detection of resistance to 15 antibiotics in 24-48 hours, compared to up to two months using standard culture-based methods. The alliance aims to advance the World Health Organization's goal of ending the global TB epidemic by 2035.News-MedicalGenoScreen’s Deeplex-MycTB test could help define appropriate treatment for tuberculosis patientsA study published in The Lancet Infectious Diseases used GenoScreen's Deeplex-MycTB test to detect multidrug-resistant tuberculosis strains missed by current tests. The test, based on DNA sequencing, predicts resistance to over a dozen antibiotics and identifies over 140 mycobacterial species. It aims to help clinicians define appropriate treatment more quickly.